Associated Banc-Corp’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-46
Closed -$5K 642
2020
Q4
$5K Sell
46
-20
-30% -$2.02K ﹤0.01% 505
2020
Q3
$5K Hold
66
﹤0.01% 449
2020
Q2
$4K Hold
66
﹤0.01% 463
2020
Q1
$2K Buy
+66
New +$1.52K ﹤0.01% 625

Other funds holding MRNA

Associated Banc-Corp's MRNA Position: Q1 2021 in Review

Associated Banc-Corp sold out of Moderna (MRNA) in Q1 2021, closing a stake of 46 shares — an estimated $5K sold.

Associated Banc-Corp first reported a position in MRNA in Q1 2020 and held it in 4 quarters. The position peaked at $5K in Q4 2020. 776 funds tracked by Wall St. Rank hold MRNA as of Q1 2021.

  • Associated Banc-Corp reported no remaining Moderna position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 46 Moderna shares in Q1 2021, an estimated $5K.
  • Associated Banc-Corp first reported a position in Moderna in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Moderna position peaked at $5K in Q4 2020.
  • 776 funds tracked by Wall St. Rank held Moderna as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.